Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01699412Phase 3Completed
A Phase 3 trial of clobetasol, dexamethasone in graft-versus-host disease (GVHD), sponsored by Grupo de Estudos Multicêntricos em Onco-Hematologia. Started Aug 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01699412.